PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer

Figure 8

(a) Univariate Cox analysis of PCMT1 gene expression and clinical characteristics. (b) Multivariate Cox analysis of PCMT1 gene expression and clinical characteristics. (c) The nomogram can predict the overall survival of breast cancer patients at 1, 2, and 3 years. (d) Calibration curve for the disease specific survival nomogram model.

(a)

(b)

(c)

(d)